Description
An ATP-competitive, selective inhibitor of ALK (Ki = i = 0.7 nM) with strong activity against all known ALK and ROS1 mutants identified in patients; orally available with efficient blood-brain barrier penetration
Formal name: (10R)-7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile
Synonyms: Lorlatinib
Molecular weight: 406.4
CAS: 1454846-35-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Receptor Tyrosine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling